Skip to main content
HIPAA Path
Category: OCR Enforcement and Penalties

Information Blocking Disincentives

Also known as: Info Blocking Disincentives, Disincentives for Information Blocking
Simply put

Information Blocking Disincentives are consequences that federal agencies can impose on health care providers who knowingly and unreasonably interfere with the access, exchange, or use of electronic health information. They were finalized by the U.S. Department of Health and Human Services (HHS) in 2024 as part of the broader effort to discourage practices that block the sharing of electronic health data. These disincentives apply specifically to health care providers, while other regulated parties may face different penalties.

Formal definition

Information Blocking Disincentives are measures established under HHS regulation that an appropriate agency may impose on a health care provider that the HHS Office of Inspector General (OIG) determines has committed information blocking. For providers, information blocking is generally defined as knowingly engaging in practices that are unreasonable and likely to interfere with the access, exchange, or use of electronic health information (EHI). The disincentive structure, finalized in 2024, is distinct from the civil monetary penalties that may apply to other regulated actors (such as developers of certified health IT and health information networks/exchanges). These provisions arise under the information blocking framework codified at 45 CFR Part 171 and are separate from HIPAA obligations enforced by HHS OCR; readers should note that information blocking rules operate under a different statutory and regulatory authority than the HIPAA Privacy, Security, and Breach Notification Rules. Specific applicability, determination processes, and the nature of individual disincentives should be verified against the current regulatory text, as details and scope may be updated over time.

Why it matters

Information Blocking Disincentives represent a significant shift in how federal regulators enforce the sharing of electronic health information. For years, the information blocking framework identified prohibited conduct, but the specific consequences for health care providers who engaged in such conduct were not fully established. With HHS finalizing disincentives for providers in 2024, providers now face concrete consequences when the HHS Office of Inspector General (OIG) determines they have knowingly and unreasonably interfered with the access, exchange, or use of electronic health information (EHI). This raises the practical stakes for organizations that had treated interoperability obligations as aspirational rather than enforceable.

Understanding this term matters because the disincentive structure applies specifically to health care providers, and is generally distinct from the civil monetary penalties that may apply to other regulated actors such as developers of certified health IT and health information networks or exchanges. Compliance teams need to correctly identify which category their organization falls into, since the nature of the consequences differs by actor type. Misclassifying an organization's role could lead to preparing for the wrong enforcement mechanism.

Equally important, these provisions arise under the information blocking framework and operate under a different statutory and regulatory authority than the HIPAA Privacy, Security, and Breach Notification Rules enforced by HHS OCR. Organizations should not assume that HIPAA compliance addresses information blocking obligations, or vice versa. Because the details, applicability, and scope of individual disincentives may be updated over time, readers should verify specifics against the current regulatory text rather than relying on summaries.

Who it's relevant to

Health Care Providers
Providers are the specific category of actor subject to information blocking disincentives as finalized in 2024. Provider compliance, privacy, and health IT leaders should understand that knowingly and unreasonably interfering with the access, exchange, or use of EHI can result in an OIG determination of information blocking and the imposition of disincentives by an appropriate agency. They should verify the specific disincentives and determination processes against the current regulation.
Compliance and Regulatory Officers
Compliance officers need to correctly distinguish information blocking obligations, which operate under a different statutory and regulatory authority, from HIPAA obligations enforced by HHS OCR. They should also confirm whether their organization is classified as a health care provider (subject to disincentives) or as another regulated actor (which may face different penalties), because the enforcement consequences differ by actor type.
Health IT Developers and Health Information Networks/Exchanges
These actors fall under the broader information blocking framework but are generally subject to consequences distinct from the provider disincentives finalized in 2024, such as civil monetary penalties. Teams in these organizations should verify the specific enforcement mechanisms that apply to their actor category against the current regulatory text.
Healthcare Legal Counsel
Attorneys advising healthcare clients should be aware that the disincentive framework is separate from the HIPAA Privacy, Security, and Breach Notification Rules and arises under a different authority. Because applicability, scope, and the nature of individual disincentives may be updated over time, counsel should confirm all specifics against the current regulation when advising clients.

Inside Information Blocking Disincentives

Information Blocking (Underlying Concept)
Practices by regulated actors that, except as required by law or covered by an exception, are likely to interfere with, prevent, or materially discourage the access, exchange, or use of electronic health information (EHI). Disincentives are the consequences applied to certain actors found to have engaged in such conduct. Note this framework arises under the 21st Century Cures Act and ONC/ASTP rules, which are distinct from the HIPAA Privacy, Security, and Breach Notification Rules; readers should verify specifics against current regulatory text.
Disincentives vs. Penalties
The term 'disincentives' generally refers to consequences established for certain healthcare providers found to have committed information blocking, as opposed to the civil monetary penalties applicable to other regulated actors such as developers of certified health IT and health information networks or exchanges. The distinction turns on the type of actor involved.
Regulated Actors Subject to Disincentives
Disincentives generally apply to healthcare providers as defined under the applicable rules. This is a different category and enforcement pathway than the penalty structure applied to other actors, and it is separate from HIPAA covered entity and business associate designations, which govern different obligations.
Enforcement Authority
Enforcement of information blocking and its consequences involves federal agencies under the Cures Act framework (such as HHS components and ONC/ASTP), which is distinct from HHS OCR's enforcement of HIPAA. Practitioners should not assume HIPAA enforcement mechanisms and information blocking disincentives are administered under the same authority or standards.
Exceptions Framework
The information blocking rules generally include defined exceptions under which conduct that might otherwise interfere with access, exchange, or use of EHI does not constitute information blocking. Meeting an exception is typically fact-specific; the precise conditions should be confirmed against the current regulatory text.
Relationship to HIPAA
Information blocking disincentives are separate from HIPAA compliance obligations. Complying with HIPAA does not by itself establish compliance with the information blocking rules, and the permitted and required uses and disclosures under the HIPAA Privacy Rule interact with, but are not identical to, the information blocking framework. State law and other frameworks may impose additional requirements.

Common questions

Answers to the questions practitioners most commonly ask about Information Blocking Disincentives.

Are information blocking disincentives part of HIPAA enforcement?
No. Information blocking disincentives arise under the 21st Century Cures Act framework and are separate from HIPAA's enforcement structure administered by HHS OCR. While both relate to health information, information blocking provisions govern the improper interference with access, exchange, or use of electronic health information, whereas HIPAA governs the privacy and security of protected health information. Readers should treat these as distinct legal regimes and verify the applicable authorities and current guidance for each, as obligations and enforcement mechanisms differ.
Do information blocking disincentives apply to every organization that handles health data?
No. Disincentives generally apply to specific categories of actors defined under the applicable Cures Act rules, rather than to every vendor or entity that touches health data. This differs from the common assumption that any data-handling organization is automatically subject to the same obligations. The scope of who is affected, and the nature of the applicable consequence, depends on the actor category and the governing rule. Readers should confirm whether a given organization falls within a defined actor category under current regulatory text.
How do information blocking disincentives relate to an organization's existing HIPAA compliance program?
They are typically addressed as a separate but complementary workstream. Because HIPAA and information blocking provisions have distinct scopes and enforcement authorities, an organization generally cannot rely on its HIPAA compliance activities alone to satisfy information blocking obligations. In most cases, organizations coordinate privacy, security, health information management, and IT functions so that access and exchange practices are evaluated against both frameworks. Readers should verify the specific requirements and any applicable exceptions against current regulatory guidance.
How should an organization document that a practice fits an information blocking exception rather than a disincentive-triggering behavior?
Organizations generally maintain contemporaneous documentation of the reasoning, conditions, and safeguards supporting reliance on a recognized exception. This typically includes recording the factual basis for a decision to limit access, exchange, or use, and how it aligns with the conditions of the applicable exception. Because the exceptions and their conditions are defined in the governing rules and may be updated over time, readers should confirm the current requirements and structure documentation to demonstrate that the specific conditions were met.
Who within an organization typically owns responsibility for managing information blocking risk?
Responsibility is commonly shared across roles rather than assigned to a single function. Privacy officers, security officers, health information management staff, IT and interoperability teams, and legal counsel often collaborate, since determinations about access and exchange can involve technical capabilities, policy decisions, and legal analysis. The precise allocation depends on organizational structure and the actor category involved. Readers should confirm ownership against their governance model and current regulatory guidance.
What steps can help an organization assess its exposure to information blocking disincentives?
A common approach is to first determine whether the organization falls within a defined actor category under the applicable rules, then inventory the practices, systems, and policies that affect access, exchange, and use of electronic health information. From there, organizations typically evaluate whether any practices could be viewed as interference and whether recognized exceptions may apply. Because the applicable consequences and conditions vary by actor category and are subject to change, readers should verify their assessment against current regulatory text and guidance.
How should information blocking considerations be reflected in vendor and system arrangements?
Organizations often review contracts, configurations, and interoperability capabilities to identify terms or technical settings that could unnecessarily restrict access or exchange of electronic health information. In most cases this is coordinated with existing HIPAA arrangements, but it is a distinct analysis, since a business associate agreement addresses HIPAA obligations and does not by itself resolve information blocking questions. Readers should confirm the applicable requirements and any exceptions against current regulatory guidance before relying on specific contract or configuration approaches.

Common misconceptions

Information blocking disincentives are part of HIPAA and enforced by HHS OCR.
The information blocking framework generally arises under the 21st Century Cures Act and ONC/ASTP rules, not the HIPAA Privacy, Security, or Breach Notification Rules. Enforcement involves federal agencies under that framework rather than HHS OCR's HIPAA enforcement, and readers should verify the specific enforcing authority against current guidance.
Every actor that engages in information blocking faces the same civil monetary penalties.
The consequences generally differ by actor type. 'Disincentives' typically apply to certain healthcare providers, while civil monetary penalties generally apply to other regulated actors such as certified health IT developers and health information networks or exchanges. The applicable consequence depends on the category of actor involved.
Withholding or limiting access to electronic health information always constitutes information blocking.
The rules generally recognize defined exceptions, and conduct required by law is treated differently. Whether a practice constitutes information blocking is typically fact-specific and depends on whether an applicable exception is met, which should be confirmed against the current regulatory text.

Best practices

Determine which regulatory category applies to your organization, since consequences generally differ between healthcare providers (subject to disincentives) and other actors such as certified health IT developers and health information networks (subject to penalties); verify actor definitions against current rules.
Do not treat HIPAA compliance as sufficient for the information blocking framework; assess your practices under both regimes separately, recognizing that permitted or required disclosures under the HIPAA Privacy Rule are not identical to information blocking obligations.
Review each information blocking exception carefully and document, on a fact-specific basis, how your organization's practices meet an applicable exception when limiting access, exchange, or use of EHI.
Confirm the responsible enforcement authority and current consequence structures against the latest ONC/ASTP and HHS guidance rather than assuming HHS OCR HIPAA enforcement mechanisms apply.
Check whether state law or other frameworks impose additional requirements beyond the federal information blocking rules and reconcile any conflicts with counsel.
Because specific figures, thresholds, and regulatory citations are adjusted over time, verify any penalty or disincentive details against the current published regulatory text before relying on them.